Sahm ScreenerSaudi Stock Screenerفلتر الأسهم السعودية
Home / Almujtama Alraida Medical Co. / 2025 Annual Results

Almujtama Alraida Medical Co. 2025 Annual Results

Revenue
SAR 455M
Net Profit
SAR 8M
EPS
SAR 0.88
Operating Cash Flow
SAR 25M

Almujtama Alraida Medical Co. (9592) reported full year 2025 revenue of SAR 455M, up 5.6% from SAR 431M in 2024. Net profit came in at SAR 8M, up 5.8% year on year. Earnings per share were SAR 0.88. The company generated SAR 25M in operating cash flow. All figures sourced from CMA-mandated XBRL filings on the Saudi Exchange, processed by Sahm Screener.

Earnings Quality

Of every SAR 1.00 in reported net profit, SAR 2.98 arrived as operating cash flow — indicating Exceptional quality earnings with a cash conversion ratio of 2.98.

Key Financial Metrics

Metric20252024
RevenueSAR 455MSAR 431M
Net ProfitSAR 8MSAR 8M
Net Margin1.9%1.8%
ROE5.7%5.7%
EPSSAR 0.88SAR 0.83
Total AssetsSAR 515MSAR 459M
Total EquitySAR 146MSAR 138M
Total LiabilitiesSAR 369MSAR 321M
Operating Cash FlowSAR 25MSAR 51M

Year on Year Comparison

Revenue increased by 5.6% compared to 2024. Net profit increased by 5.8%. Both revenue and profit grew — indicating expanding business.

View full company profile →
View all years:
2025202420232022

Financial data sourced from CMA-mandated XBRL filings published on the Saudi Exchange (Tadawul). Data processed and structured by Sahm Screener (sahmscreener.com). Updated nightly. Last updated: 2026-03-24.